医学
囊性纤维化
囊性纤维化跨膜传导调节器
皮肤病科
血管炎
病理
内科学
疾病
作者
Aaron D Smith,Gabrielle Schwartzman,Catherine E. Lyons,Richard Flowers,Dana Albon,Kenneth E. Greer,Kevin Lonabaugh,Barrett J. Zlotoff
标识
DOI:10.1016/j.jaad.2024.04.052
摘要
Cystic fibrosis (CF) is caused by a mutation in the Cystic fibrosis transmembrane conductance regulator (CFTR) gene, and features recurrent sinus and pulmonary infections, steatorrhea, and malnutrition. CF is associated with diverse cutaneous manifestations, including transient reactive papulotranslucent acrokeratoderma of the palms, nutrient deficiency dermatoses, and vasculitis. Rarely these are presenting symptoms of CF, prior to pulmonary or gastrointestinal sequelae. Cutaneous drug eruptions are also highly common in patients with CF (PwCF) given frequent antibiotic exposure. Finally, CFTR modulating therapy, which has revolutionized CF management, is associated with cutaneous side effects ranging from acute urticaria to toxic epidermal necrolysis. Recognition of dermatologic clinical manifestations of CF is important to appropriately care for PwCF. Dermatologists may play a significant role in the diagnosis and management of CF and associated skin complications.
科研通智能强力驱动
Strongly Powered by AbleSci AI